Scott Dylla
Director/Board Member at KINETA, INC.
Net worth: 2 560 $ as of 29/04/2024
Profile
Scott J.
Dylla is the founder of Stemcentrx, Inc. which was founded in 2008.
He held the title of Director & Chief Scientific Officer at Stemcentrx, Inc. Dr. Dylla's current job positions include Chairman at Driver Bioengineering, Inc. since 2019, Director at 3D Bio Holdings, Inc. since 2020, and Independent Director at Kineta, Inc. starting in 2023.
Dr. Dylla's education history includes an undergraduate degree from the University of Minnesota and a graduate degree from The University of Alabama at Birmingham.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
KINETA, INC.
0.04% | 24/04/2024 | 4,000 ( 0.04% ) | 2 560 $ | 29/04/2024 |
Scott Dylla active positions
Companies | Position | Start |
---|---|---|
KINETA, INC. | Director/Board Member | 30/06/2023 |
Driver Bioengineering, Inc.
Driver Bioengineering, Inc. Medical SpecialtiesHealth Technology Driver Bioengineering, Inc. develops modular, drug-responsive, titratable, ribozyme based control devices for chimeric antigen receptor. It engages in building control systems for chimeric antigen receptor (CAR) T-cell therapeutics. The company was founded by Gusti Zeiner, Christina Smolke and Benjamin Wang on May 12, 2015 and is headquartered in Menlo Park, CA. | Chairman | 31/05/2019 |
3D Bio Holdings, Inc.
3D Bio Holdings, Inc. Packaged SoftwareTechnology Services 3D Bio Holdings, Inc. develops term clinical applications. It focuses on whole tissue living implants. The company was founded by Hod Lipson, Larry Bonassar and Daniel L. Cohen and is headquartered in Brooklyn, NY. | Director/Board Member | 29/10/2020 |
Former positions of Scott Dylla
Companies | Position | End |
---|---|---|
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Stemcentrx, Inc. develops life-changing therapies for cancer patients. It develops proprietary discovery platforms that yield unprecedented insight into the biology of tumors and are being exploited to develop potent new cancer drugs. The firm specializes in designing drugs to target cancer stem cells, which are the cells that cause cancer to spread throughout the body. The company was founded by Brian Christopher Slingerland, Daniel T. Reiner and Scott J. Dylla in 2008 and is headquartered in San Francisco, CA. | Founder | - |
Training of Scott Dylla
University of Minnesota | Undergraduate Degree |
The University of Alabama at Birmingham | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
KINETA, INC. | Health Technology |
Private companies | 3 |
---|---|
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Stemcentrx, Inc. develops life-changing therapies for cancer patients. It develops proprietary discovery platforms that yield unprecedented insight into the biology of tumors and are being exploited to develop potent new cancer drugs. The firm specializes in designing drugs to target cancer stem cells, which are the cells that cause cancer to spread throughout the body. The company was founded by Brian Christopher Slingerland, Daniel T. Reiner and Scott J. Dylla in 2008 and is headquartered in San Francisco, CA. | Health Technology |
Driver Bioengineering, Inc.
Driver Bioengineering, Inc. Medical SpecialtiesHealth Technology Driver Bioengineering, Inc. develops modular, drug-responsive, titratable, ribozyme based control devices for chimeric antigen receptor. It engages in building control systems for chimeric antigen receptor (CAR) T-cell therapeutics. The company was founded by Gusti Zeiner, Christina Smolke and Benjamin Wang on May 12, 2015 and is headquartered in Menlo Park, CA. | Health Technology |
3D Bio Holdings, Inc.
3D Bio Holdings, Inc. Packaged SoftwareTechnology Services 3D Bio Holdings, Inc. develops term clinical applications. It focuses on whole tissue living implants. The company was founded by Hod Lipson, Larry Bonassar and Daniel L. Cohen and is headquartered in Brooklyn, NY. | Technology Services |
- Stock Market
- Insiders
- Scott Dylla